Can clinical benefits of modulators effectively 'modulate' adherence in people with CF?

Thorax. 2021 Sep;76(9):854-855. doi: 10.1136/thoraxjnl-2021-216974. Epub 2021 Apr 16.

Authors

Chelsea S Davis¹, Jonathan D Cogen²

Affiliations

¹ Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, Washington, USA chelsea.davis@seattlechildrens.org.
² Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, Washington, USA.

PMID: 33863830
DOI: 10.1136/thoraxjnl-2021-216974

No abstract available

Keywords: cystic fibrosis.

Publication types

Editorial
Comment

MeSH terms

Aminophenols*
Cystic Fibrosis Transmembrane Conductance Regulator*
Humans

Substances

Aminophenols
Cystic Fibrosis Transmembrane Conductance Regulator